Sherri R Davies

发表

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Li Ding, David Fenyö, Jason M Held, 2017, Nature Communications.

A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

Mark T. W. Ebbert, Samuel Leung, Charles M Perou, 2010, Clinical Cancer Research.

Computational identification and functional validation of regulatory motifs in cartilage-expressed genes.

Xiaoyun Xing, Li-Wei Chang, Gary D Stormo, 2007, Genome research.

Breast tumors educate the proteome of stromal tissue in an individualized but coordinated manner

Li Ding, David Fenyö, Jason M Held, 2017, Science Signaling.

Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.

Li Ding, Joshua F. McMichael, Ron Bose, 2013, Cell reports.

Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels*

Ronald J Moore, Vladislav A Petyuk, Feng Yang, 2014, Molecular & Cellular Proteomics.

Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts*

David Fenyö, Henry Rodriguez, Paul M Thomas, 2015, Molecular & Cellular Proteomics.

Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers.

Li Ding, David Fenyö, D R Mani, 2018, Cancer research.

Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays.

Michael J MacCoss, Jing Chen, Brendan MacLean, 2016, Methods in molecular biology.

Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues.

Chen, Li, Christopher R Kinsinger, 2017, Journal of proteome research.